Wird geladen...

Immune modulation by molecular cancer targets and targeted therapies: Rationale for novel combination strategies

Following our recent observation that alterations of the Natural Killer (NK) cell compartment in the presence of BCR-ABL-induced myeloproliferation fail to revert under targeted therapy, we discuss by what mechanisms oncogenic molecular pathways and their pharmacological inhibition may interfere wit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Rossig, Claudia
Format: Artigo
Sprache:Inglês
Veröffentlicht: Landes Bioscience 2012
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3382876/
https://ncbi.nlm.nih.gov/pubmed/22737614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.18401
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!